Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patients With Solid Tumors”

5,503 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 5,503 results

Early research (Phase 1)Study completedNCT00006254
What this trial is testing

VNP20009 in Treating Patients With Advanced Solid Tumors

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
Vion Pharmaceuticals
Early research (Phase 1)Study completedNCT00734305
What this trial is testing

Phase I Safety Study of the Drug MM-121 in Patients With Advanced Solid Tumors Resisting Ordinary Treatment

Who this might be right for
Advanced Solid Tumors
Merrimack Pharmaceuticals 44
Early research (Phase 1)Study completedNCT01598129
What this trial is testing

ONCOS-102 (Previously CGTG-102) for Therapy of Advanced Cancers

Who this might be right for
Malignant Solid Tumour
Targovax Oy 12
Early research (Phase 1)Active Not RecruitingNCT05354323
What this trial is testing

NECVAX-NEO1 in Addition to Checkpoint Inhibitor in Patients With Solid Tumors

Who this might be right for
Solid Tumors, Adult
NEC OncoImmunity AS 6
Early research (Phase 1)Study completedNCT00448396
What this trial is testing

Evaluate the Effects of Patupilone on the Pharmacokinetics and Pharmacodynamics of Warfarin in Patients With Advanced Malignancies

Who this might be right for
Advanced Malignancies
Novartis Pharmaceuticals 17
Early research (Phase 1)Looking for participantsNCT06859762
What this trial is testing

A First-in-Human Study of YL217 in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor
MediLink Therapeutics (Suzhou) Co., Ltd. 220
Early research (Phase 1)Study completedNCT02454062
What this trial is testing

A Trial of TAS-114 in Combination With S-1

Who this might be right for
Advanced Solid Tumors
Taiho Oncology, Inc. 120
Early research (Phase 1)Study completedNCT03713905
What this trial is testing

Study of Recombinant Human Anti-PD-1 Monoclonal Antibody for Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Guangzhou Gloria Biosciences Co., Ltd. 293
Early research (Phase 1)Study completedNCT02095054
What this trial is testing

Regorafenib and Cetuximab in Patients With Advanced Malignancy

Who this might be right for
Advanced Cancers
M.D. Anderson Cancer Center 39
Early research (Phase 1)Study completedNCT02902237
What this trial is testing

TTF-NGR Phase I Study

Who this might be right for
Malignant Solid TumorsLymphomas
University Hospital Muenster 24
Early research (Phase 1)Study completedNCT00217373
What this trial is testing

Vaccine Therapy, GM-CSF, and Interferon Alfa-2b in Treating Patients With Locally Advanced or Metastatic Cancer That Expresses Carcinoembryonic Antigen (CEA)

Who this might be right for
Adult Solid Neoplasm
National Cancer Institute (NCI) 33
Early research (Phase 1)Study completedNCT02482441
What this trial is testing

A Phase 1a/b Dose Escalation Study of the Safety, Pharmacokinetics, and Pharmacodynamics of OMP-131R10

Who this might be right for
Advanced Relapsed TumorsRefractory Solid Tumors
OncoMed Pharmaceuticals, Inc. 50
Early research (Phase 1)Looking for participantsNCT06225856
What this trial is testing

An Open-Label, Multicenter, Phase I Study to Evaluate the Safety, Pharmacokinetics and Preliminary Efficacy of YY201 in Patients With Advanced Solid Tumors and Hematological Malignancies

Who this might be right for
Advanced Solid TumorHematological Malignancy
Shanghai Yuyao Biotech Co., Ltd. 96
Early research (Phase 1)Study completedNCT03015324
What this trial is testing

Biological Effects of Agent on PAR-4 Levels With Resected Solid Tumors

Who this might be right for
Solid Tumor
Peng Wang, MD PhD 38
Early research (Phase 1)Study completedNCT01004861
What this trial is testing

Safety Study of PLX108-01 in Patients With Solid Tumors

Who this might be right for
Solid Tumor
Daiichi Sankyo 132
Early research (Phase 1)Study completedNCT00101270
What this trial is testing

Oxaliplatin and Irinotecan in Treating Young Patients With Refractory Solid Tumors or Lymphomas

Who this might be right for
Childhood Burkitt LymphomaChildhood Central Nervous System Germ Cell TumorChildhood Diffuse Large Cell Lymphoma+26 more
National Cancer Institute (NCI) 24
Testing effectiveness (Phase 2)Looking for participantsNCT06006169
What this trial is testing

BL-B01D1, SI-B003 and BL-B01D1+SI-B003 in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma and Other Solid Tumors

Who this might be right for
Head and Neck Squamous Cell Carcinoma
Sichuan Baili Pharmaceutical Co., Ltd. 186
Testing effectiveness (Phase 2)Study completedNCT00387322
What this trial is testing

Pemetrexed Disodium and Erlotinib in Treating Patients With Advanced Non-Small Cell Lung Cancer or Other Solid Tumors

Who this might be right for
Lung CancerUnspecified Adult Solid Tumor, Protocol Specific
University of California, Davis 42
Testing effectiveness (Phase 2)Ended earlyNCT04465760
What this trial is testing

Xisomab 3G3 for the Prevention of Catheter-Associated Thrombosis in Patients With Cancer Receiving Chemotherapy

Who this might be right for
LymphomaMalignant Solid NeoplasmPlasma Cell Myeloma
OHSU Knight Cancer Institute 9
Early research (Phase 1)Ended earlyNCT05698888
What this trial is testing

Study of VP301 in Patients With Multiple Myeloma, Lymphoma, or Solid Tumors

Who this might be right for
Solid Tumors, AdultMultiple MyelomaLymphoma
Virtuoso BINco, Inc. 2
Load More Results